Carvedilol and Oxymetazoline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carvedilol (carvedilol) and Oxymetazoline (oxymetazoline). Common drug interactions include dehydration among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Carvedilol and Oxymetazoline. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Carvedilol?

Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,649 Carvedilol users. Check the latest studies of Carvedilol.

What is Oxymetazoline?

Oxymetazoline has active ingredients of oxymetazoline. eHealthMe is studying from 149 Oxymetazoline users. Check the latest studies of Oxymetazoline.



On Jul, 12, 2026

11 people who take Carvedilol and Oxymetazoline together, and have interactions are studied.

Carvedilol and Oxymetazoline drug interactions.

What are the common drug interactions of Carvedilol and Oxymetazoline, by gender? *:

female:

  1. Dehydration (dryness resulting from the removal of water)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Concussion (short loss of normal brain function in response to a head injury)
  4. Drug ineffective
  5. Head injury
  6. Nausea (feeling of having an urge to vomit)
  7. Pulmonary embolism (blockage of the main artery of the lung)

male:

  1. Pneumonia
  2. Anal infection
  3. Pneumonia fungal
  4. Chronic kidney disease
  5. Renal failure (kidney dysfunction)
  6. Anaemia (lack of blood)
  7. Anxiety
  8. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  9. Death
  10. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)

What are the common drug interactions of Carvedilol and Oxymetazoline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dehydration (dryness resulting from the removal of water)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Renal failure (kidney dysfunction)
  4. Anxiety
  5. Death
  6. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  7. Pneumonia
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Chronic kidney disease

60+:

  1. Pneumonia
  2. Anal infection
  3. Anaemia (lack of blood)
  4. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  5. Concussion (short loss of normal brain function in response to a head injury)
  6. Head injury
  7. Nausea (feeling of having an urge to vomit)
  8. Pneumonia bacterial (pneumonia associated with bacterial infection)
  9. Pneumonia fungal

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 54.55%
  2. Nosebleed (bleeding from nose): 5 people, 45.45%
  3. Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 5 people, 45.45%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 36.36%
  5. Sleep Disorder: 4 people, 36.36%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 36.36%
  7. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 36.36%
  8. Neuropathy Peripheral (surface nerve damage): 4 people, 36.36%
  9. Type 2 Diabetes: 4 people, 36.36%
  10. Allergic Rhinitis: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Carvedilol and Oxymetazoline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Carvedilol and Oxymetazoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carvedilol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxymetazoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carvedilol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxymetazoline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on carvedilol and oxymetazoline (the active ingredients of Carvedilol and Oxymetazoline, respectively), and Carvedilol and Oxymetazoline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: